✦ LIBER ✦

Prognostic value of estrogen and progesterone receptors in operable breast cancer

✍ Scribed by B. Chevallier; B. Asselain; P. Bastit; V. Graic; M. Comoz; J.P. Dauce; J.P. Basuyau

Book ID: 116006491
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 126 KB
Volume: 28
Category: Article
ISSN: 0022-4731
DOI: 10.1016/0022-4731(87)91160-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic value of estrogen and progest

Prognostic value of estrogen and progesterone receptors in operable breast cancer: Results of a univariate and multivariate analysis

✍ Bernard Chevallier; Francois Heintzmann; Veronique Mosseri; Jean Paul Dauce; Phi 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 654 KB

Prognostic value of estrogen and progest

Prognostic value of estrogen and progesterone receptors in primary breast cancer

✍ Simone Saez; Françoise Cheix; Bernard Asselain 📂 Article 📅 1983 🏛 Springer US 🌐 English ⚖ 760 KB

669 Long term (> 10 years) prognost

669 Long term (> 10 years) prognostic value of estrogen and progesterone receptors for operable breast cancer

✍ L. Mauriac; F. Bonichon; M. Durand; J. Wafflart; A. Avril 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Prognostic value of estrogen and progest

Prognostic value of estrogen and progesterone receptors in primary infiltrating ductal breast cancer

✍ Spyratos, F.; Hacene, K.; Tubiana-Hulin, M.; Pallud, C.; Brunet, M. 📂 Article 📅 1989 🏛 Elsevier Science ⚖ 835 KB

Prognostic value of estrogen receptors i

Prognostic value of estrogen receptors in primary breast cancer

✍ Prof. Roland Hähnel; Drrernat; Terry Woodings; A. Brian Vivian 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB 👁 2 views

Prognostic significance of estrogen and

Prognostic significance of estrogen and progesterone receptors in stage ii breast cancer

✍ Stefan Rydén; Mårten Fernö; Åke Borg; Larsolof Hafström; Torgil Möller; Allan No 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

Estrogen (ER) and progesterone receptors (PgR) were evaluated in samples from primary tumors in 539 patients with stage I1 breast cancer participating in a randomized multicenter controlled clinical trial on adjuvant therapy. At the cut-off points of 10 fmol EWmg protein and 30 fmol PgR/ mg protein,